• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RNA 结合蛋白 POP7 通过调控 ILF3 mRNA 的稳定性和表达促进乳腺癌的进展。

RNA binding protein POP7 regulates ILF3 mRNA stability and expression to promote breast cancer progression.

机构信息

Department of Breast Surgery, Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, China.

Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.

出版信息

Cancer Sci. 2022 Nov;113(11):3801-3813. doi: 10.1111/cas.15430. Epub 2022 Sep 6.

DOI:10.1111/cas.15430
PMID:35579257
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9633317/
Abstract

RNA binding proteins (RBPs) play pivotal roles in breast cancer (BC) development. As an RBP, Processing of precursor 7 (POP7) is one of the subunits of RNase P and RNase MRP, however, its exact function and mechanism in BC remain unknown. Here, we showed that expression of POP7 was frequently increased in BC cells and in primary breast tumors. Upregulated POP7 significantly promoted BC cell proliferation in vitro and primary tumor growth in vivo. POP7 also increased cell migration, invasion in vitro, and lung metastasis in vivo. Through RNA immunoprecipitation coupled with sequencing (RIP-seq), we found that POP7 bound preferentially to intron regions and POP7-binding peak associated genes were mainly enriched in cancer-related pathways. Furthermore, POP7 regulated Interleukin Enhancer Binding Factor 3 (ILF3) expression through influencing its mRNA stability. Knockdown of ILF3 significantly impaired the increased malignant potential of POP7-overexpressing cells, suggesting that POP7 enhances BC progression through regulating ILF3 expression. Collectively, our findings provide the first evidence for the important role of POP7 and its regulation of ILF3 in promoting BC progression.

摘要

RNA 结合蛋白 (RBPs) 在乳腺癌 (BC) 的发展中起着关键作用。作为 RBP,前体加工蛋白 7 (POP7) 是 RNase P 和 RNase MRP 的亚基之一,但其在 BC 中的确切功能和机制尚不清楚。在这里,我们表明 POP7 的表达在 BC 细胞和原发性乳腺癌肿瘤中经常增加。上调的 POP7 显著促进了 BC 细胞在体外的增殖和体内原发性肿瘤的生长。POP7 还增加了细胞迁移、侵袭的体外能力,并增加了体内的肺转移。通过 RNA 免疫沉淀结合测序 (RIP-seq),我们发现 POP7 优先结合内含子区域,POP7 结合峰相关基因主要富集在癌症相关途径中。此外,POP7 通过影响其 mRNA 稳定性来调节白细胞介素增强因子 3 (ILF3) 的表达。ILF3 的敲低显著削弱了过表达 POP7 的细胞恶性潜能的增加,表明 POP7 通过调节 ILF3 的表达来增强 BC 的进展。总之,我们的研究结果为 POP7 及其调节 ILF3 促进 BC 进展的重要作用提供了第一个证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02a7/9633317/13087c4067b3/CAS-113-3801-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02a7/9633317/7dd6a6aaf137/CAS-113-3801-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02a7/9633317/7fa63d9bb98a/CAS-113-3801-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02a7/9633317/0c1982ce0e51/CAS-113-3801-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02a7/9633317/1f7ac511eb2f/CAS-113-3801-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02a7/9633317/2ff7cee18cb1/CAS-113-3801-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02a7/9633317/13087c4067b3/CAS-113-3801-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02a7/9633317/7dd6a6aaf137/CAS-113-3801-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02a7/9633317/7fa63d9bb98a/CAS-113-3801-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02a7/9633317/0c1982ce0e51/CAS-113-3801-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02a7/9633317/1f7ac511eb2f/CAS-113-3801-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02a7/9633317/2ff7cee18cb1/CAS-113-3801-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02a7/9633317/13087c4067b3/CAS-113-3801-g007.jpg

相似文献

1
RNA binding protein POP7 regulates ILF3 mRNA stability and expression to promote breast cancer progression.RNA 结合蛋白 POP7 通过调控 ILF3 mRNA 的稳定性和表达促进乳腺癌的进展。
Cancer Sci. 2022 Nov;113(11):3801-3813. doi: 10.1111/cas.15430. Epub 2022 Sep 6.
2
Interleukin enhancer-binding factor 3 promotes breast tumor progression by regulating sustained urokinase-type plasminogen activator expression.白细胞介素增强结合因子 3 通过调节持续的尿激酶型纤溶酶原激活物表达促进乳腺癌进展。
Oncogene. 2013 Aug 22;32(34):3933-43. doi: 10.1038/onc.2012.414. Epub 2012 Sep 17.
3
LncRNA PTTG3P promotes tumorigenesis and metastasis of NSCLC by binding with ILF3 to maintain mRNA stability and form a positive feedback loop with E2F1.长链非编码 RNA PTTG3P 通过与 ILF3 结合来维持 mRNA 稳定性,并与 E2F1 形成正反馈环,从而促进 NSCLC 的肿瘤发生和转移。
Int J Biol Sci. 2023 Aug 21;19(13):4291-4310. doi: 10.7150/ijbs.81738. eCollection 2023.
4
Characterization of circSCL38A1 as a novel oncogene in bladder cancer via targeting ILF3/TGF-β2 signaling axis.环状 RNA SCL38A1 通过靶向 ILF3/TGF-β2 信号轴作为膀胱癌的新型癌基因的特征。
Cell Death Dis. 2023 Jan 25;14(1):59. doi: 10.1038/s41419-023-05598-2.
5
Long non-coding RNA ILF3-AS1 facilitates hepatocellular carcinoma progression by stabilizing ILF3 mRNA in an mA-dependent manner.长非编码 RNA ILF3-AS1 通过 mA 依赖性方式稳定 ILF3 mRNA 促进肝癌进展。
Hum Cell. 2021 Nov;34(6):1843-1854. doi: 10.1007/s13577-021-00608-x. Epub 2021 Sep 7.
6
PSMD3-ILF3 signaling cascade drives lung cancer cell proliferation and migration.PSMD3-ILF3 信号级联促进肺癌细胞增殖和迁移。
Biol Direct. 2023 Jun 19;18(1):33. doi: 10.1186/s13062-023-00389-3.
7
RNA stability protein ILF3 mediates cytokine-induced angiogenesis.RNA 稳定性蛋白 ILF3 介导细胞因子诱导的血管生成。
FASEB J. 2019 Mar;33(3):3304-3316. doi: 10.1096/fj.201801315R. Epub 2018 Nov 1.
8
Oncogenic splicing factor SRSF3 regulates ILF3 alternative splicing to promote cancer cell proliferation and transformation.致癌剪接因子 SRSF3 通过调节 ILF3 的可变剪接促进癌细胞增殖和转化。
RNA. 2019 May;25(5):630-644. doi: 10.1261/rna.068619.118. Epub 2019 Feb 22.
9
ILF3 is a substrate of SPOP for regulating serine biosynthesis in colorectal cancer.ILF3 是 SPOP 的底物,可调节结直肠癌中的丝氨酸生物合成。
Cell Res. 2020 Feb;30(2):163-178. doi: 10.1038/s41422-019-0257-1. Epub 2019 Nov 26.
10
The long non-coding RNA ILF3-AS1 increases the proliferation and invasion of retinoblastoma through the miR-132-3p/SMAD2 axis.长链非编码 RNA ILF3-AS1 通过 miR-132-3p/SMAD2 轴促进视网膜母细胞瘤的增殖和侵袭。
Exp Cell Res. 2020 Aug 15;393(2):112087. doi: 10.1016/j.yexcr.2020.112087. Epub 2020 May 11.

引用本文的文献

1
Integrative bioinformatics analysis identifies METTL1 as a regulator of immune infiltration and prognosis in breast cancer.整合生物信息学分析确定METTL1为乳腺癌免疫浸润和预后的调节因子。
Sci Rep. 2025 Jul 19;15(1):26297. doi: 10.1038/s41598-025-11391-2.
2
RNA binding protein ILF3 increases CEP55 mRNA stability to enhance malignant potential of breast cancer cells and suppress ferroptosis.RNA结合蛋白ILF3提高CEP55 mRNA稳定性,以增强乳腺癌细胞的恶性潜能并抑制铁死亡。
Hereditas. 2025 Jan 27;162(1):10. doi: 10.1186/s41065-025-00372-0.
3
RBM8A, a new target of TEAD4, promotes breast cancer progression by regulating IGF1R and IRS-2.

本文引用的文献

1
RNA-Binding Proteins CLK1 and POP7 as Biomarkers for Diagnosis and Prognosis of Esophageal Squamous Cell Carcinoma.RNA结合蛋白CLK1和POP7作为食管鳞状细胞癌诊断和预后的生物标志物
Front Cell Dev Biol. 2021 Sep 9;9:715027. doi: 10.3389/fcell.2021.715027. eCollection 2021.
2
RNA-Binding Proteins in Cancer: Functional and Therapeutic Perspectives.癌症中的RNA结合蛋白:功能与治疗前景
Cancers (Basel). 2020 Sep 21;12(9):2699. doi: 10.3390/cancers12092699.
3
Decoding mRNA translatability and stability from the 5' UTR.从 5'UTR 解码 mRNA 的翻译能力和稳定性。
TEAD4 的新靶标 RBM8A 通过调节 IGF1R 和 IRS-2 促进乳腺癌进展。
J Transl Med. 2024 Sep 4;22(1):823. doi: 10.1186/s12967-024-05639-0.
4
CircRNAs: Pivotal modulators of TGF-β signalling in cancer pathogenesis.环状RNA:癌症发病机制中转化生长因子-β信号通路的关键调节因子
Noncoding RNA Res. 2024 Jan 26;9(2):277-287. doi: 10.1016/j.ncrna.2024.01.013. eCollection 2024 Jun.
5
Impaired histone inheritance promotes tumor progression.染色质遗传缺陷促进肿瘤进展。
Nat Commun. 2023 Jun 10;14(1):3429. doi: 10.1038/s41467-023-39185-y.
6
NUDT1 Could Be a Prognostic Biomarker and Correlated with Immune Infiltration in Clear Cell Renal Cell Carcinoma.NUDT1可能是一种预后生物标志物,且与透明细胞肾细胞癌中的免疫浸润相关。
Appl Bionics Biomech. 2022 Dec 26;2022:3669296. doi: 10.1155/2022/3669296. eCollection 2022.
7
Network Pharmacology Analysis, Molecular Docking, and Verification Reveal the Action Mechanism of L. in Treating Breast Cancer.网络药理学分析、分子对接及验证揭示L.治疗乳腺癌的作用机制
Evid Based Complement Alternat Med. 2022 Aug 10;2022:5481563. doi: 10.1155/2022/5481563. eCollection 2022.
Nat Struct Mol Biol. 2020 Sep;27(9):814-821. doi: 10.1038/s41594-020-0465-x. Epub 2020 Jul 27.
4
RNA-binding proteins in tumor progression.肿瘤进展中的 RNA 结合蛋白。
J Hematol Oncol. 2020 Jul 11;13(1):90. doi: 10.1186/s13045-020-00927-w.
5
The Tristetraprolin Family of RNA-Binding Proteins in Cancer: Progress and Future Prospects.癌症中RNA结合蛋白的Tristetraprolin家族:进展与未来展望
Cancers (Basel). 2020 Jun 11;12(6):1539. doi: 10.3390/cancers12061539.
6
Discrete functional and mechanistic roles of chromodomain Y-like 2 (CDYL2) transcript variants in breast cancer growth and metastasis.CDYL2 转录本变体在乳腺癌生长和转移中的离散功能和机制作用。
Theranostics. 2020 Apr 6;10(12):5242-5258. doi: 10.7150/thno.43744. eCollection 2020.
7
Acetylation of MORC2 by NAT10 regulates cell-cycle checkpoint control and resistance to DNA-damaging chemotherapy and radiotherapy in breast cancer.NAT10 介导的 MORC2 乙酰化调控乳腺癌细胞周期检查点控制和对 DNA 损伤化疗和放疗的抵抗。
Nucleic Acids Res. 2020 Apr 17;48(7):3638-3656. doi: 10.1093/nar/gkaa130.
8
Cancer the'RBP'eutics-RNA-binding proteins as therapeutic targets for cancer.癌症的“RBP 疗法”——RNA 结合蛋白作为癌症的治疗靶点。
Pharmacol Ther. 2019 Nov;203:107390. doi: 10.1016/j.pharmthera.2019.07.001. Epub 2019 Jul 11.
9
Cancer-Associated MORC2-Mutant M276I Regulates an hnRNPM-Mediated CD44 Splicing Switch to Promote Invasion and Metastasis in Triple-Negative Breast Cancer.癌症相关的 MORC2 突变 M276I 通过调控 hnRNPM 介导的 CD44 剪接开关促进三阴性乳腺癌的侵袭和转移。
Cancer Res. 2018 Oct 15;78(20):5780-5792. doi: 10.1158/0008-5472.CAN-17-1394. Epub 2018 Aug 9.
10
FBXO22 Possesses Both Protumorigenic and Antimetastatic Roles in Breast Cancer Progression.FBXO22 在乳腺癌进展中具有促肿瘤发生和抗转移的双重作用。
Cancer Res. 2018 Sep 15;78(18):5274-5286. doi: 10.1158/0008-5472.CAN-17-3647. Epub 2018 Jun 26.